NCT02941081View on ClinicalTrials.gov

A Novel Nano-iron Supplement to Safely Combat Iron Deficiency and Anaemia in Young Children: a Doubleblind Randomised Controlled Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

645

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

November 22, 2018

Study Completion Date

May 28, 2019

Conditions
Iron Deficiency, Anaemia in Children
Interventions
DIETARY_SUPPLEMENT

IHAT

1 dose/day single IMP containing IHAT powder bioequivalent to 12.5 mg Fe (i.e. 20 mg Fe taking into account IHAT's relative bioavailability to FeSO4)

DIETARY_SUPPLEMENT

Ferrous Sulphate

1 dose/day single IMP containing FeSO4 powder equivalent to 12.5 mg Fe

OTHER

Placebo

1 dose/day containing a placebo powder (no-iron, 'sugar' compound)

Trial Locations (1)

Unknown

MRC Unit The Gambia, Basse Santa Su

All Listed Sponsors
collaborator

National Nutrition Agency (NaNa), The Gambia

UNKNOWN

collaborator

Wellcome Trust

OTHER

collaborator

King's College London

OTHER

collaborator

University of Cambridge

OTHER

collaborator

MRC UK Biostatistics Unit

UNKNOWN

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT02941081 - A Novel Nano-iron Supplement to Safely Combat Iron Deficiency and Anaemia in Young Children: a Doubleblind Randomised Controlled Trial | Biotech Hunter | Biotech Hunter